Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1140331 | 1.00 | GPR84 (0.59) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL4850789 | 1.00 | GPR84 (0.59) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL5190857 | 0.93 | GPR84 (0.63) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL5189024 | 0.93 | GPR84 (0.63) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL4726364 | 0.93 | GPR84 (0.63) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL4867571 | 0.91 | GPR84 (0.67) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL10386437 | 0.91 | GPR84 (0.67) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL10386445 | 0.91 | GPR84 (0.67) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL10386906 | 0.91 | GPR84 (0.67) | GPR84SLC22A6FFAR4FFAR1LMNA | |
| SCHEMBL2727566 | 0.91 | GPR84 (0.67) | GPR84SLC22A6FFAR4FFAR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661836-A | Preparation method of intrinsic ultra-fast moisture-absorbing quick-drying nylon slice and application of intrinsic ultra-fast moisture-absorbing quick-drying nylon slice in nylon | 浙江恒逸石化研究院有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-1594853-B1 | METHOD FOR THE PRODUCTION OF BICYCLIC AROMATIC AMINO ACIDS AND INTERMEDIATE PRODUCTS THEREOF | MERCK PATENT GMBH (DE) | 2008-07-09 | — | — | EP | claimed |
| CN-119661836-A | Preparation method of intrinsic ultra-fast moisture-absorbing quick-drying nylon slice and application of intrinsic ultra-fast moisture-absorbing quick-drying nylon slice in nylon | 浙江恒逸石化研究院有限公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-3845580-B1 | ALIPHATIC POLYESTER WITH HIGH ELONGATION | CHANG CHUN PLASTICS CO LTD (TW) | 2023-10-25 | — | — | EP | disclosed |
| US-20230295195-A1 | ANTIMICROBIAL ORGANOSILANES | Tipikos Pharmaceuticals, Inc. (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230143708-A1 | ANTIMICROBIAL ORGANOSILANES | TOPIKOS PHARMACEUTICALS, INC. (US) | 2023-05-11 | — | — | US | disclosed |
| US-11427676-B2 | Aliphatic polyester with high elongation | CHANG CHUN PLASTICS CO., LTD. (TW) | 2022-08-30 | — | — | US | disclosed |
| CN-111138646-B | High ductility aliphatic polyester | 长春人造树脂厂股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114430738-A | Programmable polymeric pharmaceuticals | 索尼集团公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114302725-A | Oral administration combination of beta lactam antibiotic and avibactam derivative for the treatment of bacterial infections | 阿里萨制药公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-114072178-A | Programmable polymeric pharmaceuticals | 索尼集团公司 | 2022-02-18 | — | — | CN | disclosed |
| WO-2003090690-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030203458-A1 | Coloring composition for color filters containing microencapsulated pigment composed of polyhydroxyalkanoate | CANON KABUSHIKI KAISHA (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030203987-A1 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-06-19 | — | — | US | disclosed |
| US-20030104302-A1 | Construct and method for making it | LASALLE BANK NATIONAL ASSOCIATION | 2003-06-05 | — | — | US | disclosed |
| EP-1275728-A1 | Polyhydroxyalkanoate-containing structure and manufacturing method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-1262229-A1 | Coloring composition containing a pigment coated by a polyhydroxyalkanoate | CANON KABUSHIKI KAISHA (JP) | 2002-12-04 | — | — | EP | disclosed |
| EP-1256606-A2 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2002-11-13 | — | — | EP | disclosed |
| EP-1253160-A2 | Construct and method for making it | CANON KABUSHIKI KAISHA (JP) | 2002-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | LIPA, ABHD16A, LIPE | GPR84 1255/4885SLC22A6 569/4885FFAR4 198/4885 |
| US-20230143708-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | GPR84 4425/4885SLC22A6 1842/4885FFAR4 4447/4885 |
| US-20230295195-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | GPR84 4425/4885SLC22A6 1842/4885FFAR4 4447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.